Incidence of Coronavirus Infection in Patients Undergoing Kidney Transplant During the Pandemic Period in Uzbekistan
CONCLUSIONS: The Ministry of Health of the Republic of Uzbekistan indicated the possibility of treatment of patients with moderate and severe COVID-19 disease with monoclonal antibodies that block interleukin 6 receptors (tocilizumab and sarilumab). With timely detection of symptoms of COVID-19infection, treatment, and the use of prevention methods, kidney transplant recipients of living related donors had fewer complications of the disease than expected.PMID:36018027 | DOI:10.6002/ect.DonorSymp.2022.O15
Source: Experimental and Clinical Transplantation : official journal of the Middle East Society for Organ Transplantation - Category: Transplant Surgery Authors: Fazlitdin Sh Bakhritdinov Ravshan A Ibadov Marguba T Azimova Zokhidjon T Matkarimov Dildora N Komilova Nigina B Elmurodova Source Type: research
More News: Actemra | Coronavirus | COVID-19 | CT Scan | Dialysis | Glomerulonephritis | Hemodialysis | Intensive Care | Kidney Transplant | Kidney Transplantation | Liver | Liver Transplant | Lung Transplant | Middle East Health | Pandemics | Pneumonia | Pyelonephritis | Renal Failure | Transplant Surgery | Transplants | Urology & Nephrology | Uzbekistan Health